Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$37.6M
3M shares
52-week range
$1.52 – $16.89
68% from low
Sector
SERVICES-HEALTH SERVICES
Exchange
NASDAQ
CS
Borrow rate
39.97%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $87.7M | $145.5M | $491.1M | $637.4M | $1.05B | $1.27B | $1.50B | $1.46B |
| Cost of revenue | $0 | $0 | $0 | $668.1M | $0 | $0 | $0 | $1.60B |
| Gross profit | $87.7M | $145.5M | $491.1M | −$30.7M | $1.05B | $1.27B | $1.50B | −$144.3M |
| Gross margin | 100.0% | 100.0% | 100.0% | -4.8% | 100.0% | 100.0% | 100.0% | -9.9% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$49.7M | −$39.5M | −$28.6M | −$187.9M | −$1.56B | −$167.9M | −$320.7M | −$270.3M |
| EBITDA | −$49.4M | −$39.0M | −$28.1M | −$184.6M | −$1.46B | −$81.1M | −$197.8M | −$186.1M |
| Net income | −$43.8M | −$42.0M | −$31.4M | −$156.5M | −$270.1M | −$57.8M | −$135.8M | −$147.9M |
| Net margin | -49.9% | -28.8% | -6.4% | -24.6% | -25.7% | -4.6% | -9.1% | -10.1% |
| EPS (diluted) | -92.04 | -44.10 | -39.73 | -188.17 | -324.84 | -30.44 | -54.06 | -45.26 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1.5B | $-8.45 | $-8.58–$-8.31 | 1 |
| 2027 | $1.6B | $-3.00 | $-7.32–$1.33 | 2 |
Forward consensus · source: Financial Modeling Prep
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.
www.p3hp.orgNo one on the platform currently holds PIII.
No tracked institution reports a position in PIII as of their last filing.
| Execution date | Ratio |
|---|---|
| 2025-04-14 | 1-for-50reverse |
No one on the platform has traded PIII yet.
| $8M |
| — |
| ITRMIterum Therapeutics plc | $0.03 | -10.98% | $2M | — |
| PSTVPlus Therapeutics, Inc. | $4.29 | +2.14% | $10M | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 0.0× sales vs its 0.1× historical median P/S.
Fair value ≈ $73.13 · price $11.94 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$PIII this should be over $15 for sure and much higher if profits are made
View on StockTwits ↗$PIII a little surprised this didn't run today with $AGL. it will soon though, imo. i was a buyer in the 10's today and will add on any further dips. looking for an explosive move upwards after q2 earnings are reported.
View on StockTwits ↗$PIII reinstated Nasdaq listing compliance after Nasdaq staff confirmed it meets Rule 5550(b)(2).
View on StockTwits ↗$BESS $WETO $PIII $JDZG A few multi day movers to keep on watch this week
View on StockTwits ↗$PIII I read ur posts. Thank you very interesting. I own shares as it obviously under accumulation. 20s soon.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.